FDA
Articles tagged with “FDA”
FDA Moves Against Illegal Ketamine Sellers in 2026
The FDA is targeting illegal ketamine sellers in 2026. Here's what this enforcement action means for patients using compounded ketamine troches.
FDA Review of Preservative-Free Ketamine Advances
NRx Pharmaceuticals reports progress on FDA review of its preservative-free ketamine application. Here's what it could mean for troche access and compounding.
NRx's FDA Push for Preservative-Free Ketamine Explained
NRx Pharmaceuticals reports FDA progress on a preservative-free ketamine application. Here's what it means for troche access, compounding, and home dosing.
Compounded Ketamine vs. Brand-Name Spravato: Full Comparison
Compounded racemic ketamine troches vs FDA-approved Spravato (esketamine): efficacy data, cost gap, access barriers, and clinical suitability compared.
FDA Status of Compounded Ketamine Troches
Compounded ketamine troches are not FDA-approved but are legal under 503A. Prescriber liability, regulatory status, and what it means for patients.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.